Psilocybin works twice as well as nicotine patches!

Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives

Dr. Matthew Johnson’s research found that 59% of nicotine-addicted patients remained abstinent from smoking for 12 months after receiving a single macrodose of psilocybin. Only 28% of patients on a nicotine patch remained abstinent for the same time period.

His other research shows that multiple psilocybin doses can have an 80% success rate!

Primary Logo

PDF of article

How to cure depression in two hours

GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical Trial of GH001 in Treatment-Resistant Depression

GH Research (GHRS) discovered that the most powerful psychedelic, 5-MeO-DMT (aka toad venom), is highly effective at curing treatment-resistant depression.

Out of eight patients, seven were in remission from depression just one day after receiving the company’s proprietary formulation, and five of those were in remission in as little as two hours. 

All eight patients showed improved depression scores, with an average reduction of 76%. 

GH Research Logo

PDF of article

Curing the worst pain known to humans

Take Two Shrooms and Call Me in the Morning: The Medical Promise of Magic Mushrooms

For years, Brad Badelt suffered from debilitating cluster headaches (which are often called “suicide headaches” and described as the worst pain known to humans).

After seeing countless neurologists, chiropractors, acupuncturists, and naturopaths, he would still experience the horrible headaches several times a day for weeks on end.

After taking one dose of shrooms, things finally changed. 

“When I woke the next morning, I felt different: the mental fog brought on by my cluster headaches was gone. For the next twelve months, I remained headache free. Every year since, I’ve downed a dose of shrooms, and every year my cluster headaches have remained in remission.”

The first psychedelic studies program in Canada

How Dr. Monnica Williams Created Canada’s First Psychedelic Master’s Degree Program: ‘Nobody Took Me Seriously’

This semester, the University of Ottawa launched a three-course “microprogram” on Psychedelics and Spirituality. The school will offer a master’s program in psychedelics in the fall of 2022 and aims to develop a Ph.D. program after that!

Why?

“I was getting emails almost on a daily basis from people who wanted to know how they could become psychedelic therapists,” said Dr. Monica Williams, who created the program.

Benzinga

PDF of article

Mushrooms go high fashion

Californian firm touts ‘mushroom leather’ as sustainability gamechanger

According to the Higg Materials Sustainability Index, leather causes more environmental damage than any other fabric. Mushrooms are now being used as a sustainable alternative!

In a matter of weeks, mushroom mycelium can be grown into a material that looks and feels just like leather. It’s actually stronger and more durable than real leather 🤯

Even high fashion brands like Hermès are using the material!

PDF of article

More positive findings from biggest psilocybin trial

COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression

COMPASS Pathways (CMPS) announced additional findings from the world’s largest psilocybin trial for depression. 

In addition to reduced depression scores, patients showed improvements in anxiety, daily functioning, cognition, and quality of life. Just one day after the treatment, patients had increased positive feelings such as “interested, excited, strong” and decreased negative feelings like “distressed, upset, afraid.” 

PDF of Article

Antidepressants + psilocybin

MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybin

Do patients need to come off of antidepressants before trying psilocybin therapy?

New research from MindMed (MNMD) and Liechti Labs suggests that it’s not necessary – and there are actually benefits of combining the two.

Escitalopram (aka Lexapro) did not affect the way psilocybin was processed and helped reduce negative side effects like anxiety and high blood pressure.

PDF of Article

Get ready for a psychedelic TV series coming this summer!

LA Mag’s Psychedelics Cover Story Is Being Developed As TV Series

This month’s issue of Los Angeles Magazine features an in-depth cover story on the city’s recent obsession with psychedelics.

Now, the story is being developed into a drama/comedy series called Psychedelic City (think Silicon Valley meets Limitless).

The writer hopes the show will “wipe away some of the stigmas that have been attached to psychedelics.”

The developers are also creating a Psychedelic City metaverse platform with immersive art, music, and experimental therapies.

PDF of article

Ayahuasca vs placebo

Ayahuasca users report psychological benefits after taking placebo at a ritualistic ceremony

An ayahuasca retreat could make you more empathetic!

In a recent study, participants reported reduced stress, anxiety, and depression after attending an ayahuasca ceremony… even those who were given a placebo.

However, only the ayahuasca users showed increased empathy.

The supportive group atmosphere could explain why people experienced benefits even without taking ayahuasca.

PDF of article